bNOS

Bacterial nitric oxide synthase (bNOS) is a key enzyme involved in the synthesis of nitric oxide (NO) from L-arginine, playing critical roles in microbial physiology, stress resistance, and virulence. Recent studies have demonstrated that NO produced by bNOS enhances bacterial resistance to a broad spectrum of antibiotics by mitigating oxidative stress and chemically modifying toxic compounds, thereby enabling survival in environments with antibiotic-producing microorganisms^[1]. This protective role is particularly evident in Gram-positive bacteria such as Staphylococcus aureus and Mycobacterium tuberculosis, where bNOS contributes to antibiotic resistance and biofilm formation^[2]. Furthermore, bNOS activity has been linked to virulence regulation, with its inhibition sensitizing pathogens to host immune defenses and enhancing the efficacy of antimicrobial therapy^[3]. The identification of bNOS inhibitors, especially those targeting unique structural features like the Ile residue in the active site distinct from mammalian NOS isoforms, offers promising therapeutic strategies for combating drug-resistant infections^[4]. In addition, novel mechanisms such as the interaction between bNOS and tryptophanyl tRNA synthetase in Deinococcus radiodurans suggest previously unknown biological functions of bNOS beyond NO production^[5]. These findings collectively highlight bNOS as a pivotal target in both fundamental microbial biology and translational medicine.